Literature DB >> 2856849

Hepatitis B vaccination. Response of alcoholic with and without liver injury.

C Mendenhall1, G A Roselle, L A Lybecker, L E Marshall, C J Grossman, S A Myre, R E Weesner, D D Morgan.   

Abstract

Alcoholics are at risk to develop hepatitis B infections, chronic active hepatitis, and even hepatoma. Hence, immunization with hepatitis B vaccine is recommended. However, immune abnormalities may coexist which alter their responsiveness to vaccination. This study compares the immune response to this vaccine in controls (group I), alcoholics without overt liver disease (group II), and alcoholics with clinical liver disease (group III). By the seventh month after the initial vaccination, 89% in group I, 70% in group II, and 18% in group III had a response greater than 36 RIA units. The magnitude of the response was significantly different in groups I, II, and III (19,456 vs 8,326 vs 153 RIA units, respectively; P less than 0.05, group I vs III). In those who did not respond, a significant (P less than 0.02) lower helper/inducer (T4) class of lymphocytes was observed as compared to patients who exhibited an adequate response. These observations suggest: (1) that the response to hepatitis B vaccine is a T-cell-dependent event and (2) that in this population, using the existing vaccine, postvaccination evaluations of antibody concentrations are needed before protection against hepatitis B infection can be assumed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2856849     DOI: 10.1007/bf01535747

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  32 in total

1.  The production of antibody by patients with chronic hepatic disease.

Authors:  W P HAVENS; J M SHAFFER; C J HOPKE
Journal:  J Immunol       Date:  1951-10       Impact factor: 5.422

2.  Prevalence of markers of hepatotrophic viruses in alcoholics with symptomatic liver cirrhosis or pancreatitis.

Authors:  L Stigendal; S Hermodsson; R Olsson
Journal:  Scand J Gastroenterol       Date:  1984-07       Impact factor: 2.423

3.  Evidence for previous hepatitis B virus infection in alcoholic cirrhosis.

Authors:  C Buffet; P Attali; L Papoz; J C Chaput; J P Etienne
Journal:  Dig Dis Sci       Date:  1982-05       Impact factor: 3.199

Review 4.  Role of nutrition in immunologic function.

Authors:  R L Gross; P M Newberne
Journal:  Physiol Rev       Date:  1980-01       Impact factor: 37.312

5.  Ethanol, immune reactions and the digestive system.

Authors:  N Kanagasundaram; C M Leevy
Journal:  Clin Gastroenterol       Date:  1981-05

6.  Immune function in severe, active rheumatoid arthritis: a relationship between peripheral blood mononuclear cell proliferation to soluble antigens and mononuclear cell subset profiles.

Authors:  B Haraoui; R L Wilder; D G Malone; J B Allen; I M Katona; S M Wahl
Journal:  J Immunol       Date:  1984-08       Impact factor: 5.422

7.  Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy.

Authors:  C E Stevens; H J Alter; P E Taylor; E A Zang; E J Harley; W Szmuness
Journal:  N Engl J Med       Date:  1984-08-23       Impact factor: 91.245

8.  Hepatitis B vaccine in health care personnel: safety, immunogenicity, and indicators of efficacy.

Authors:  J L Dienstag; B G Werner; B F Polk; D R Snydman; D E Craven; R Platt; C S Crumpacker; R Ouellet-Hellstrom; G F Grady
Journal:  Ann Intern Med       Date:  1984-07       Impact factor: 25.391

9.  The prevention of hepatitis B with vaccine. Report of the centers for disease control multi-center efficacy trial among homosexual men.

Authors:  D P Francis; S C Hadler; S E Thompson; J E Maynard; D G Ostrow; N Altman; E H Braff; P O'Malley; D Hawkins; F N Judson; K Penley; T Nylund; G Christie; F Meyers; J N Moore; A Gardner; I L Doto; J H Miller; G H Reynolds; B L Murphy; C A Schable; B T Clark; J W Curran; A G Redeker
Journal:  Ann Intern Med       Date:  1982-09       Impact factor: 25.391

10.  In vitro antigen-induced antibody responses to hepatitis B surface antigen in man. Kinetic and cellular requirements.

Authors:  T R Cupps; J L Gerin; R H Purcell; P K Goldsmith; A S Fauci
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

View more
  18 in total

1.  Effect of age and frequency of injections on immune response to hepatitis B vaccination in drug users.

Authors:  Thanh Q Tran; Carolyn Z Grimes; Dejian Lai; Catherine L Troisi; Lu-Yu Hwang
Journal:  Vaccine       Date:  2011-11-08       Impact factor: 3.641

2.  Response to HBV vaccination in patients with severe liver disease. Absence of an HLA effect.

Authors:  D H Van Thiel; J S Gavaler
Journal:  Dig Dis Sci       Date:  1992-09       Impact factor: 3.199

3.  Response to hepatitis B vaccination by liver transplant candidates.

Authors:  D H Van Thiel; L el-Ashmawy; K Love; J S Gavaler; T E Starzl
Journal:  Dig Dis Sci       Date:  1992-08       Impact factor: 3.199

4.  Review.

Authors:  Usman Khokhar; Debra Stevens; Linda K Shipton; Daryl T-Y Lau
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-09

5.  Hepatitis B vaccine response before and after transplantation in 55 extrahepatic biliary atresia children.

Authors:  E M Sokal; L Ulla; J B Otte
Journal:  Dig Dis Sci       Date:  1992-08       Impact factor: 3.199

6.  Independent clinical predictors of impaired response to hepatitis B vaccination in HIV-infected persons.

Authors:  H Nina Kim; Robert D Harrington; Stephen E Van Rompaey; Mari M Kitahata
Journal:  Int J STD AIDS       Date:  2008-09       Impact factor: 1.359

7.  Safety and efficacy of hepatitis B vaccination in cirrhosis of liver.

Authors:  D Ajith Roni; Rama Mohan Pathapati; A Sathish Kumar; Lalit Nihal; K Sridhar; Sujith Tumkur Rajashekar
Journal:  Adv Virol       Date:  2013-06-06

Review 8.  Immunizations in chronic liver disease: what should be done and what is the evidence.

Authors:  Michael D Leise; Jayant A Talwalkar
Journal:  Curr Gastroenterol Rep       Date:  2013-01

9.  Levels of circulating follicular helper T cells, T helper 1 cells, and the prognostic significance of soluble form of CD40 ligand on survival in patients with alcoholic cirrhosis.

Authors:  Kristin Hollister; Praveen Kusumanchi; Ruth Ann Ross; Kristina Chandler; AdePeju Oshodi; Laura Heathers; Sean Teagarden; Li Wang; Alexander L Dent; Suthat Liangpunsakul
Journal:  Liver Res       Date:  2018-02-22

10.  Efficacy of double dose recombinant hepatitis B vaccination in chronic hepatitis C patients, compared to standard dose vaccination.

Authors:  Mohammad Minakari; Afshin Tahmasebi; Mahyar Hosseini Motlagh; Behrooz Ataei; Majid Yaran; Hamid Kalantari; Hamid Tavakkoli
Journal:  Int J Prev Med       Date:  2014-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.